Submitted: 04 Jun 2021
Accepted: 07 Oct 2021
ePublished: 19 Nov 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Prev Epidemiol. 2023;8(1): e19150.
doi: 10.34172/jpe.2022.19150
  Abstract View: 515
  PDF Download: 115


Metabolomics in lupus; opportunities and challenges

Sara Afshari 1 ORCID logo, Narges Kalhor 1 ORCID logo, Seyed Mojtaba Alavi 1 ORCID logo, Seyed Mohammad Hashem Montazeri 1 ORCID logo, Maryam Masoumi 2* ORCID logo

1 Student Research Committee, School of Medicine, Qom University of Medical Sciences, Qom, Iran
2 Clinical Research Development Center, Shahid Beheshti Hospital, Qom University of Medical Sciences, Qom, Iran
*Corresponding Author: Maryam Masoumi, Email: mmasoomi@muq.ac.ir


Systemic lupus erythematosus (SLE) is characterized by an inappropriate autoimmune response to self-antigens. This disease is a heterogeneous autoimmune disease that shows variable clinical course. Metabolomics employs advanced analytical chemistry techniques to comprehensively measure many small molecule metabolites in biological cells and tissues. Metabolites are downstream of translation processes and are thought to be associated with disease phenotypes. This technology is recognized as a powerful tool with excellent potential for detecting prognostic and diagnostic biomarkers in rheumatic diseases. In this review; we summarized the recent available results of studies on metabolomics in lupus and the importance of metabolomics in the finding of diagnostic and prognostic biomarkers was investigated.

Citation: Afshari S, Kalhor N, Alavi SM, Montazeri SMH , Masoumi M. Metabolomics in lupus; opportunities and challenges. J Prev Epidemiol. 2023;8(1):e19150. doi: 10.34172/ jpe.2022.19150.
First Name
Last Name
Email Address
Security code

Abstract View: 516

Your browser does not support the canvas element.

PDF Download: 115

Your browser does not support the canvas element.